VCBeat has learned that XBP Hexiyuan, an operational service provider for the medical and health innovation and entrepreneurship ecosystem, has officially announced that it has received strategic investment from Zhongxi Fund. The funds raised in this round will be primarily used to build XBP Hexiyuan’s medical and health ecosystem service system and to strengthen its professional team.
XBP Hexiyuan is a service provider specializing in the professional, chain-based operation of industrial parks within the healthcare sector, and stands as a leading domestic pioneer and demonstration operator for Marketing Authorization Holder (MAH) license commercialization. Committed to building a specialized, chain-based ecosystem platform for innovation and entrepreneurship, XBP Hexiyuan integrates industrial park investment research and strategy, industry investment promotion and operational management, innovative incubation, MAH license commercialization, industrial community management, and industrial investment.
Currently, its managed industrial parks in Hangzhou include the AHB Anhe Pharmaceutical Valley and the XBP Jinjing Digital Medical Valley. In the course of operating these two specialized life and health industrial parks in Qiantang District, Hangzhou, it has successfully attracted more than 40 high-quality enterprises across the industry chain, including listed pharmaceutical investment firms, enterprises founded by high-level talents from both domestic and overseas markets, and Marketing Authorization Holder (MAH) license holders. Notably, it has established China’s first demonstration industrial park for MAH license commercialization, namely the AHB Anhe Pharmaceutical Valley.
On How to Build an Innovation Ecosystem Service System Conducive to Corporate Growth and Development,Gao Lijuan, Founder of XBP HexiyuanConsider:The primary principle in building an enterprise service system is altruism; only services that address genuine corporate needs are effective. The second principle is to truly “understand” enterprises, as only through such understanding can precise service matching be achieved. The final principle is connectivity, which involves leveraging external professional resources to provide robust support for specialized services. Currently, by integrating internal and external professional resources through XBP and Hexiyuan, we are able to offer enterprises a wide range of services, including startup support, financing channels, and media platforms.
“The core triad of XBP and Hexiyuan’s services comprises capital, talent, and market. To help enterprises address the funding needs essential for their development, our due diligence extends beyond the project level to delve into corporate shareholder structures and talent tiers. For entrepreneurs with high-level expertise, we provide guidance on aligning with and applying for government talent programs, which serves as the most significant non-dilutive safeguard for meeting early-stage startup capital requirements. During the implementation and growth phases, we also offer debt or equity financing matchmaking services tailored to enterprise needs.”
Gao Lijuan added, “At the same time, we are strengthening human connections. A vibrant and dynamic industrial park must fully facilitate interpersonal linkages. Connecting entrepreneurs can generate greater fission effects and chemical reactions. For instance, we organize outdoor hiking activities for entrepreneurs. These hikes are not merely intended to encourage entrepreneurs to enjoy nature and exercise outdoors; more importantly, they create scenarios for outdoor social interaction. After a long trek involving mutual support along the way, interpersonal distances shrink, and communication becomes surprisingly effective. Following each such event, entrepreneurs often report increased potential for collaboration. This brings us great joy and a strong sense of accomplishment.”
Compared with practitioners in other industries, those in the medical and health sector tend to pay more attention to the implementation of industrial ecosystems. How can an ecosystem conducive to the growth of medical and health enterprises be created? This has been the focus of XBP and Hexiyuan’s continuous reflection and efforts. Gao Lijuan stated that this is also the most critical factor driving the strategic partnership between XBP, Hexiyuan, and Zhongxi Fund. With the support of Zhongxi Fund, XBP and Hexiyuan will rapidly explore new directions in their professional layout integrating industry, innovation incubation, and fund investment.
Among the strategic investors in this round, Zhongxi Fund is a subsidiary of Zhongjun Yatai Medical Group, specializing in equity investments in the life and health sector. In addition to equity investment (Zhongxi Fund), Zhongjun Yatai operates three other major business segments: equity financing (Yatai Capital), management consulting (Fucheng Consulting), and industrial park operations (Yitu Culture).
“This investment in XBP Hexiyuan represents the final piece of our group’s strategic layout. Zhongjun Yatai plans to create an integrated model combining finance and medical parks, further building a closed-loop medical ecosystem,” said the founder of Zhongjun Yatai. “In addition to professional investment support, Zhongjun Yatai’s financing services and high-end consulting services will further help XBP Hexiyuan’s industrial clients grow rapidly, assisting XBP Hexiyuan in developing its own unique model in the exploration of specialized parks plus industrial investment.”
Following this round of strategic financing, XBP and Hangzhou Hexiyuan Industrial Management Co., Ltd. will partner with Zhongxi Fund to accelerate the development of a comprehensive healthcare ecosystem service system, better serve healthcare enterprises within the park, expedite the growth of innovative healthcare companies, and facilitate the upgrading of the healthcare industry.
About Zhongxi Fund
Zhongxi Fund focuses on early- to mid-stage investments in the healthcare and life sciences sector. Its team comprises seasoned investment banking professionals and experts with pharmaceutical backgrounds, specializing in capital operations such as investment and mergers and acquisitions. With offices established in Hangzhou, Chengdu, and Chongqing, the fund primarily covers the Jiangsu-Zhejiang-Shanghai region and Southwest China. Adhering to an industry-driven approach in selecting investment targets, Zhongxi Fund leverages its extensive resources in the biopharmaceutical industry to empower portfolio companies in securing follow-on financing, standardizing corporate operations, and integrating industrial resources. By accompanying these companies through their rapid growth, Zhongxi Fund aims to become a value creator in the biopharmaceutical industry.